cuprizone has been researched along with fingolimod hydrochloride in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antel, JP; Dukala, D; Kim, HJ; Ludwin, SK; Miron, VE; Proia, RL; Soliven, B; Traka, M | 1 |
| Apicco, D; Guckian, K; Hu, Y; Ji, B; Lee, X; Mi, S; Miller, RH; Pepinsky, RB | 1 |
| Ahmad, I; Deshmukh, VA; Gage, FH; Green, CC; Kerman, B; Kim, HJ; Kondo, T; Lairson, LL; Lawson, BR; Lyssiotis, CA; Padmanabhan, K; Schultz, PG; Swoboda, JG; Tardif, V; Theofilopoulos, AN | 1 |
| Amor, S; Beyer, C; Clarner, T; Kipp, M; Schmidt, T; Slowik, A | 1 |
| Alme, MN; Bø, L; Myhr, KM; Nystad, AE; Torkildsen, Ø; Vedeler, CA; Wergeland, S | 1 |
| Bielawski, J; Kim, S; Kong, Y; Li, J; Yang, H; Zhou, B | 1 |
| Chen, M; Kurniawan, ND; Meyer-Schell, N; Reutens, D; Sullivan, R; Vegh, V; Ziser, L | 1 |
| Bø, L; Lereim, RR; Myhr, KM; Nystad, AE; Oveland, E; Torkildsen, Ø; Wergeland, S | 1 |
| Esfandiary, E; Ghanadian, M; Ghasemi, N; Moradi, V; Rashidi, B | 1 |
| Hikida, T; Kato, TA; Li, S; Ohgidani, M; Sakurai, K | 1 |
10 other study(ies) available for cuprizone and fingolimod hydrochloride
| Article | Year |
|---|---|
Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model.
Topics: Animals; Axons; Blotting, Western; Corpus Callosum; Cuprizone; Demyelinating Diseases; Fingolimod Hydrochloride; Immunohistochemistry; Immunosuppressive Agents; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Electron; Myelin Sheath; Oligodendroglia; Propylene Glycols; Receptors, Lysosphingolipid; Reverse Transcriptase Polymerase Chain Reaction; Sphingosine | 2011 |
Sphingosine 1-phosphate receptor modulator fingolimod (FTY720) does not promote remyelination in vivo.
Topics: Animals; Chelating Agents; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Myelin Sheath; Nerve Regeneration; Propylene Glycols; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Sphingosine | 2011 |
A regenerative approach to the treatment of multiple sclerosis.
Topics: Animals; Antiparkinson Agents; Benztropine; Cell Differentiation; Coculture Techniques; Cuprizone; Encephalomyelitis, Autoimmune, Experimental; Female; Fingolimod Hydrochloride; Immune System; Mice; Mice, Inbred C57BL; Models, Biological; Multiple Sclerosis; Myelin Proteolipid Protein; Myelin Sheath; Oligodendroglia; Optic Nerve; Propylene Glycols; Rats; Receptor, Muscarinic M1; Receptor, Muscarinic M3; Recurrence; Regeneration; Sphingosine; Stem Cells | 2013 |
The sphingosine 1-phosphate receptor agonist FTY720 is neuroprotective after cuprizone-induced CNS demyelination.
Topics: Amyloid beta-Protein Precursor; Animals; Corpus Callosum; Cuprizone; Demyelinating Diseases; Fingolimod Hydrochloride; Gene Expression Regulation; Liver; Male; Membrane Proteins; Mice, Inbred C57BL; Neuroprotective Agents; Phosphatidate Phosphatase; Phosphoric Monoester Hydrolases; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Receptors, Lysosphingolipid; Sphingosine | 2015 |
Fingolimod does not enhance cerebellar remyelination in the cuprizone model.
Topics: Animals; Cerebellum; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Female; Fingolimod Hydrochloride; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Propylene Glycols; Sphingosine | 2015 |
Functional antagonism of sphingosine-1-phosphate receptor 1 prevents cuprizone-induced demyelination.
Topics: Animals; Apoptosis; Brain; Chimera; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Fingolimod Hydrochloride; Gene Expression; Gliosis; Indans; Inflammation; Male; Mice, Inbred C57BL; Mice, Transgenic; Neuroglia; Neuroprotective Agents; Oxadiazoles; Receptors, Lysosphingolipid; Sphingosine-1-Phosphate Receptors; White Matter | 2018 |
Utility of gradient recalled echo magnetic resonance imaging for the study of myelination in cuprizone mice treated with fingolimod.
Topics: Animals; Cuprizone; Fingolimod Hydrochloride; Gray Matter; Magnetic Resonance Imaging; Mice; Microglia; Myelin Basic Protein; Myelin Sheath; Parvalbumins | 2018 |
Fingolimod downregulates brain sphingosine-1-phosphate receptor 1 levels but does not promote remyelination or neuroprotection in the cuprizone model.
Topics: Animals; Brain; Cuprizone; Female; Fingolimod Hydrochloride; Mice; Mice, Inbred C57BL; Multiple Sclerosis, Relapsing-Remitting; Neuroprotection; Random Allocation; Remyelination; Sphingosine 1 Phosphate Receptor Modulators; Sphingosine-1-Phosphate Receptors | 2020 |
The effect of Zingiber Officinale Extract on Preventing Demyelination of Corpus Callosum in a Rat Model of Multiple Sclerosis
Topics: Animals; Anti-Inflammatory Agents; Corpus Callosum; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Fingolimod Hydrochloride; Male; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Myelin Sheath; Rats; Rats, Wistar; Zingiber officinale | 2022 |
Ameliorative effects of Fingolimod (FTY720) on microglial activation and psychosis-related behavior in short term cuprizone exposed mice.
Topics: Animals; Cuprizone; Fingolimod Hydrochloride; Mice; Microglia; Neuroinflammatory Diseases; Psychotic Disorders | 2023 |